Literature DB >> 12196721

Histological and immunohistochemical analysis of apocrine breast carcinoma.

Kaneyuki Matsuo1, Takashi Fukutomi, Tadashi Hasegawa, Sadako Akashi-Tanaka, Takeshi Nanasawa, Hitoshi Tsuda.   

Abstract

BACKGROUND: There are few data regarding the biological characteristics of apocrine breast carcinoma in the literature due to its rarity and controversy over its definition. We analyzed the histopathological characteristics and tumor biology of apocrine breast carcinomas with regard to histological grade, p53, HER2, bcl-2, MIB-1 and hormone receptor status. PATIENTS AND METHODS: A consecutive series of 24 female apocrine breast carcinoma patients were the primary source of these retrospective data. Background factors including histological grade, nodal status and lymphatic invasion by tumor cells were analyzed. Immunohistochemical staining for p53, HER2, MIB-1, bcl-2, estrogen receptor (ER) and progesterone receptor (PR) was carried out on formalin-fixed, paraffin embedded specimens.
RESULTS: Older age and postmenopausal status were observed more frequently in patients with apocrine breast carcinoma than those with invasive ductal carcinoma. Apocrine breast carcinoma also showed relatively lower histological grade than invasive ductal carcinoma. Nuclear accumulation of p53, HER2 overexpression, bcl-2 and MIB-1 index were observed in 29% (7/24), 33%(8/24), 25%(6/24) and 29% (7/24) of cases, respectively. Positivity for ER and PR was present in 17% (4/24) and 17% (4/24) of cases, respectively.
CONCLUSIONS: Apocrine breast carcinoma tended to show low MIB-1 index, low bcl-2 expression and low positive rate of hormone receptors. There was no correlation between the three types of apocrine carcinoma and the positivity rate of p53, HER2, bcl-2, MIB-1 and hormone receptor status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196721     DOI: 10.1007/bf02967546

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  6 in total

1.  Multiplex PCR analysis of apocrine lesions shows frequent PI3K-AKT pathway mutations in both benign and malignant apocrine breast tumors.

Authors:  Naoki Kanomata; Rin Yamaguchi; Junichi Kurebayashi; Takuya Moriya
Journal:  Med Mol Morphol       Date:  2019-05-28       Impact factor: 2.309

Review 2.  Management of unusual histological types of breast cancer.

Authors:  Karen A Cadoo; Orla McArdle; Anne-Marie O'Shea; Colm P Power; Bryan T Hennessy
Journal:  Oncologist       Date:  2012-07-23

Review 3.  The enigmatic nature of apocrine breast lesions.

Authors:  P Zagorianakou; N Zagorianakou; D Stefanou; G Makrydimas; N J Agnantis
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

4.  Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort.

Authors:  A Mukherjee; E Provenzano; R Russell; Suet-Feung Chin; B Liu; O M Rueda; H R Ali; G Turashvili; B Mahler-Araujo; I O Ellis; S Aparicio; C Caldas
Journal:  NPJ Breast Cancer       Date:  2018-03-07

5.  Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.

Authors:  Wenyu Wu; Meiying Wu; Guowen Peng; Degang Shi; Jian Zhang
Journal:  Cancer Med       Date:  2019-10-23       Impact factor: 4.452

6.  What do you think of an unusual axillary mass?

Authors:  Hafsa Benzzi; Majda Askour; Afaf Elouazani; Mouna Bouaddi; Badreddine Hassam; Amar Saidi
Journal:  Pan Afr Med J       Date:  2017-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.